Assignee
UNIV WESTERN HEALTH SCIENCES
US·10 granted patents·17 pending applications·10 citations·filing 2009–2024
Top patents by PatentIndex Score
27 records- 0184US9844557B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Dec 19, 2017·4 cites·17 claims
- 0283US9445995B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2015·Granted Sep 20, 2016·4 cites·11 claims
- 0379US9623033B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Apr 18, 2017·2 cites·13 claims
- 0461US2024249635A1Formative feedback system and methodUNIV WESTERN HEALTH SCIENCES·Filed 2024·Application pending·0 cites
- 0559US2019133946A1Novel formulation of pegylated-liposome encapsulated glycopeptide antibioticsUNIV WESTERN HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 0659US2018303850A1Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 0757US2015140092A1Coated drug delivery formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2014·Application pending·0 cites
- 0855US12209111B2Targeting P18 for mTOR-related disordersUNIV WESTERN HEALTH SCIENCES·Filed 2019·Granted Jan 28, 2025·0 cites·7 claims
- 0955US2021267896A1Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2021·Application pending·0 cites
- 1054US11229602B2Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2017·Granted Jan 25, 2022·0 cites·16 claims
- 1154US2018311166A1Ternary mixture formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 1254US2018202104A1Standardized ex vivo platforms for the antigen-specific expansion of cd4+ t cell populationsUNIV WESTERN HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 1353US9808426B2Ternary mixture formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Nov 7, 2017·0 cites·6 claims
- 1452US2013218546A1Novel gtp cyclohydrolase type ibUNIV WESTERN HEALTH SCIENCES·Filed 2012·Application pending·0 cites
- 1551US10201523B2Use of wilforlide A for overcoming chemotherapy resistanceUNIV WESTERN HEALTH SCIENCES·Filed 2014·Granted Feb 12, 2019·0 cites·5 claims
- 1651US2017231912A1Novel formulation of pegylated-liposome encapsulated glycopeptide antibioticsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 1750US2011093959A1cryptotis parva screening model for antiemetic potentialUNIV WESTERN HEALTH SCIENCES·Filed 2009·Application pending·0 cites
- 1848US2019206273A1Formative feedback system and methodUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 1945US9943578B2Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populationsUNIV WESTERN HEALTH SCIENCES·Filed 2013·Granted Apr 17, 2018·0 cites·1 claims
- 2044US2021155674A1Factor ix-transferrin fusion proteinsUNIV WESTERN HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 2144US2021179543A1Calpain-2 selective inhibitor compounds for treatment of glaucomaUNIV WESTERN HEALTH SCIENCES·Filed 2019·Application pending·0 cites
- 2240US11607384B2Lipid emulsified drug delivery systems for chemoprevention and treatmentUNIV WESTERN HEALTH SCIENCES·Filed 2018·Granted Mar 21, 2023·0 cites·17 claims
- 2340US10149876B2Tripterygium wilfordii extracts to overcome chemotherapy resistanceUNIV WESTERN HEALTH SCIENCES·Filed 2013·Granted Dec 11, 2018·0 cites·5 claims
- 2432US2019030114A1Isoform-specific calpain inhibitors, methods of identification, and uses thereofUNIV WESTERN HEALTH SCIENCES·Filed 2015·Application pending·0 cites
- 2532US2019343763A1Methods of treating upper tract urothelial carcinomasUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 2632US2019248830A1Proliposomal testosterone undecanoate formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 2718US2018021387A1Probiotic compositions and methods of useUNIV WESTERN HEALTH SCIENCES·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UNIV WESTERN HEALTH SCIENCES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →